Skip to content

A Novel IUD Insertion Technique

Introducing Trans- Abdominal Guided Intrauterine Device Insertion, a Single Blinded Randomized Control Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02582268
Enrollment
100
Registered
2015-10-21
Start date
2015-10-31
Completion date
2016-02-29
Last updated
2015-10-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Contraception

Brief summary

A previous trial performed by our research team, in order to reduce the pain associated with intrauterine device insertion, compared the novel technique of IUD insertion under the guidance of the trans-abdominal sonography to the traditional method of IUD insertion. It came up with the conclusion that the TAS guided IUD insertion is significantly lower in pain score and time taken for insertion, when compared with the traditional method. In this study our researchers aim to abolish the distracting effect of the technician and the TAS probe (which might have interfered with previous results).

Interventions

RADIATIONTrans-abdominal sonography

Sponsors

Woman's Health University Hospital, Egypt
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
FEMALE
Age
20 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* Females desiring contraception with the use of IUD * Females with history of previous vaginal delivery

Exclusion criteria

* Are pregnant or think they may be pregnant * Septic pregnancy or abortion * Have unexplained abnormal vaginal bleeding * Have untreated cervical cancer * Have malignant gestational trophoblastic disease * Have uterine cancer * Have uterine abnormalities * Have or may have had a pelvic infection within the past three months * Have or may have any sexually transmitted disease * Have pelvic tuberculosis * Are postpartum between 48 hours and 4 weeks * Have benign gestational trophoblastic disease

Design outcomes

Primary

MeasureTime frameDescription
degree of pain during IUD insertion4 monthsPain will be assessed by the use of visual analog scale (VAS).

Countries

Egypt

Contacts

Primary ContactDina M Dakhly, MD
dinadakhly@gmail.com01003498919

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 26, 2026